990 related articles for article (PubMed ID: 29791760)
21. A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys.
St Andre M; Johnson M; Bansal PN; Wellen J; Robertson A; Opsahl A; Burch PM; Bialek P; Morris C; Owens J
Skelet Muscle; 2017 Nov; 7(1):25. PubMed ID: 29121992
[TBL] [Abstract][Full Text] [Related]
22. Branched fibers in dystrophic mdx muscle are associated with a loss of force following lengthening contractions.
Chan S; Head SI; Morley JW
Am J Physiol Cell Physiol; 2007 Sep; 293(3):C985-92. PubMed ID: 17567750
[TBL] [Abstract][Full Text] [Related]
23. Pannexin 1 dysregulation in Duchenne muscular dystrophy and its exacerbation of dystrophic features in mdx mice.
Freeman E; Langlois S; Leyba MF; Ammar T; Léger Z; McMillan HJ; Renaud JM; Jasmin BJ; Cowan KN
Skelet Muscle; 2024 Apr; 14(1):8. PubMed ID: 38671506
[TBL] [Abstract][Full Text] [Related]
24. Striated muscle activator of Rho signalling (STARS) overexpression in the mdx mouse enhances muscle functional capacity and regulates the actin cytoskeleton and oxidative phosphorylation pathways.
Sadler KJ; Gatta PAD; Naim T; Wallace MA; Lee A; Zaw T; Lindsay A; Chung RS; Bello L; Pegoraro E; Lamon S; Lynch GS; Russell AP
Exp Physiol; 2021 Jul; 106(7):1597-1611. PubMed ID: 33963617
[TBL] [Abstract][Full Text] [Related]
25. Restoration of pharyngeal dilator muscle force in dystrophin-deficient (mdx) mice following co-treatment with neutralizing interleukin-6 receptor antibodies and urocortin 2.
Burns DP; Rowland J; Canavan L; Murphy KH; Brannock M; O'Malley D; O'Halloran KD; Edge D
Exp Physiol; 2017 Sep; 102(9):1177-1193. PubMed ID: 28665499
[TBL] [Abstract][Full Text] [Related]
26. A novel ex vivo protocol to mimic human walking gait: implications for Duchenne muscular dystrophy.
Bukovec KE; Hu X; Borkowski M; Jeffery D; Blemker SS; Grange RW
J Appl Physiol (1985); 2020 Oct; 129(4):779-791. PubMed ID: 32881620
[TBL] [Abstract][Full Text] [Related]
27. Dystrophin expression following the transplantation of normal muscle precursor cells protects mdx muscle from contraction-induced damage.
Rousseau J; Dumont N; Lebel C; Quenneville SP; Côté CH; Frenette J; Tremblay JP
Cell Transplant; 2010; 19(5):589-96. PubMed ID: 20650035
[TBL] [Abstract][Full Text] [Related]
28. Early myopathy in Duchenne muscular dystrophy is associated with elevated mitochondrial H
Hughes MC; Ramos SV; Turnbull PC; Rebalka IA; Cao A; Monaco CMF; Varah NE; Edgett BA; Huber JS; Tadi P; Delfinis LJ; Schlattner U; Simpson JA; Hawke TJ; Perry CGR
J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):643-661. PubMed ID: 30938481
[TBL] [Abstract][Full Text] [Related]
29. Comparative proteomic profiling of soleus, extensor digitorum longus, flexor digitorum brevis and interosseus muscles from the mdx mouse model of Duchenne muscular dystrophy.
Carberry S; Brinkmeier H; Zhang Y; Winkler CK; Ohlendieck K
Int J Mol Med; 2013 Sep; 32(3):544-56. PubMed ID: 23828267
[TBL] [Abstract][Full Text] [Related]
30. Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy.
Terrill JR; Pinniger GJ; Graves JA; Grounds MD; Arthur PG
J Physiol; 2016 Jun; 594(11):3095-110. PubMed ID: 26659826
[TBL] [Abstract][Full Text] [Related]
31. Nutraceutical and pharmaceutical cocktails did not improve muscle function or reduce histological damage in D2-mdx mice.
Spaulding HR; Quindry T; Hammer K; Quindry JC; Selsby JT
J Appl Physiol (1985); 2019 Oct; 127(4):1058-1066. PubMed ID: 31295065
[TBL] [Abstract][Full Text] [Related]
32. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P
Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419
[TBL] [Abstract][Full Text] [Related]
33. Acute AT
Meyers TA; Heitzman JA; Krebsbach AM; Aufdembrink LM; Hughes R; Bartolomucci A; Townsend D
J Mol Cell Cardiol; 2019 Mar; 128():51-61. PubMed ID: 30664850
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M
EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792
[TBL] [Abstract][Full Text] [Related]
35. A Reduction in Selenoprotein S Amplifies the Inflammatory Profile of Fast-Twitch Skeletal Muscle in the
Wright CR; Allsopp GL; Addinsall AB; McRae NL; Andrikopoulos S; Stupka N
Mediators Inflamm; 2017; 2017():7043429. PubMed ID: 28592916
[TBL] [Abstract][Full Text] [Related]
36. Postdevelopmental knockout of Orai1 improves muscle pathology in a mouse model of Duchenne muscular dystrophy.
García-Castañeda M; Michelucci A; Zhao N; Malik S; Dirksen RT
J Gen Physiol; 2022 Sep; 154(9):. PubMed ID: 35939054
[TBL] [Abstract][Full Text] [Related]
37. Force and stiffness of old dystrophic (mdx) mouse skeletal muscles.
Bobet J; Mooney RF; Gordon T
Muscle Nerve; 1998 Apr; 21(4):536-9. PubMed ID: 9533791
[TBL] [Abstract][Full Text] [Related]
38. Micro-dystrophin and follistatin co-delivery restores muscle function in aged DMD model.
Rodino-Klapac LR; Janssen PM; Shontz KM; Canan B; Montgomery CL; Griffin D; Heller K; Schmelzer L; Handy C; Clark KR; Sahenk Z; Mendell JR; Kaspar BK
Hum Mol Genet; 2013 Dec; 22(24):4929-37. PubMed ID: 23863459
[TBL] [Abstract][Full Text] [Related]
39. Poloxamer [corrected] 188 has a deleterious effect on dystrophic skeletal muscle function.
Terry RL; Kaneb HM; Wells DJ
PLoS One; 2014; 9(3):e91221. PubMed ID: 24642557
[TBL] [Abstract][Full Text] [Related]
40. Truncated dystrophins reduce muscle stiffness in the extensor digitorum longus muscle of mdx mice.
Hakim CH; Duan D
J Appl Physiol (1985); 2013 Feb; 114(4):482-9. PubMed ID: 23221959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]